Newsroom
Sorted by: Latest
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF- August 19.12.2025 GAUG LN IE000TGSG3Y5 650,002.00 USD 22,856,319.73 35.163 ...
-
Asia-Pacific Lighting Fixtures Market Report 2025: China Remains the Largest Producer in the $58 Billion Industry, Followed by Japan and India. - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "The Lighting Fixtures Market in Asia-Pacific, 2025" report has been added to ResearchAndMarkets.com's offering. Lighting Fixtures production in Asia-Pacific exceeds USD 58 billion. China remains the largest producer of lighting fixtures in the area, followed by Japan and India. Exports account for about half of total production, with North America being the primary destination. Among the major exporting countries, Vietnam, the second-largest exporter, also stands o...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Scarce Resources UCTS ETF 19.12.2025 SCAR LN IE000BW2B3J3 25,002.00 USD 672,170.61 26.885 ...
-
Samenvatting: Incyte Japan maakt de goedkeuring bekend van Minjuvi® (tafasitamab) in combinatie met rituximab en lenalidomide voor de behandeling van gerecidiveerd of refractair folliculair lymfoom
TOKIO--(BUSINESS WIRE)--Incyte Biosciences Japan G.K. maakte vandaag bekend dat het Japanse MHLW (Ministry of Health, Labour & Welfare) Minjuvi® (tafasitamab) in combinatie met rituximab en lenalidomide heeft goedgekeurd voor volwassen patiënten met gerecidiveerd of refractair folliculair lymfoom (2L+ FL). “De goedkeuring van vandaag voor Minjuvi in combinatie met rituximab en lenalidomide betekent een belangrijke mijlpaal als eerste dubbel gerichte CD19 en CD20 immunotherapiecombinatie ter...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share FIRST TRUST INDXX FUTURE ECONOMY METALS UCITS ETF 19.12.2025 METL LN IE000UDFKE13 75,002.00 USD 2,308,272.67 30.776 ...
-
XCharge and EnBW Begin Expanded Testing of Fast-Charging Infrastructure
HAMBURG, Germany--(BUSINESS WIRE)--XCharge is cooperating in testing with EnBW on their fast-charging-network, the EnBW HyperNet in Germany. Since August 2025, EnBW has deployed one charger to complement a location near Stuttgart. Now, an important step in the collaboration was made and a field test with 10 charging stations at four different locations has started. The test includes two XCharge units at EnBW’s site in EnBW City in Stuttgart and three other sites; Rutesheim, Karlsruhe (Durlach C...
-
Riassunto: Incyte Japan annuncia l'approvazione di Zynyz® (retifanlimab) per il trattamento di prima linea del cancro anale in fase avanzata
TOKYO--(BUSINESS WIRE)--Incyte Biosciences Japan G.K. ha annunciato oggi l'approvazione da parte del Ministero giapponese della Salute, del Lavoro e del Welfare (MHLW) di Zynyz® (retifanlimab) in combinazione con carboplatino e paclitaxel (terapia chemioterapica a base di platino) per il trattamento di prima linea del carcinoma a cellule squamose in fase avanzata del canale anale (SCAC). "L'approvazione di oggi segna un importante traguardo per i pazienti affetti da cancro anale allo stadio ava...
-
Resumen: Incyte Japón anuncia la aprobación de Zynyz® (retifanlimab) para el tratamiento de primera línea del cáncer anal avanzado.
TOKIO--(BUSINESS WIRE)--Incyte Biosciences Japan G.K. acaba de anunciar la aprobación por parte del Ministerio de Salud, Trabajo y Bienestar de Japón (MHLW) de Zynyz® (retifanlimab) en combinación con carboplatino y paclitaxel (quimioterapia basada en platino) para los tratamientos de primera línea del carcinoma escamoso avanzado del canal anal (SCAC). «La aprobación por parte del MHLW de Zynyz como el primer y único tratamiento de primera línea para el SCAC marca un importante hito para los pa...
-
Connecticut’s HIE, Connie, Implements Clinical Architecture’s PIQXL Gateway to Improve Patient Data Quality Statewide
CARMEL, Ind. & ROCKY HILL, Conn.--(BUSINESS WIRE)--Connie, Connecticut’s state-designated Health Information Exchange (HIE), is implementing Clinical Architecture’s PIQXL Gateway to help healthcare organizations across Connecticut assess and strengthen the quality of shared patient data. The solution enables Connie to evaluate incoming messages, identify where data quality breaks down, and provide participants with actionable insights. PIQXL Gateway is the first commercial solution built on the...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Low Duration Global Government Bond UCITS ETF 19.12.2025 FGOV LN IE00BKS2X200 33,638.00 GBP 496,009.40 16.825 ...